TL;DR: Isabl is a Y Combinator Winter 2020 startup Cancer tests based on whole genome and transcriptome data., currently active with a team of 5.
Cancer tests based on whole genome and transcriptome data.
Last verified:
Isabl has developed software that can analyze the entire genome of cancer patients. Today, when people get cancer, they get a genetic test of their tumor that analyzes only a few possible mutations. With Isabl, you run the tumor through an Illumina sequencer and get the whole genome, then our software is able to analyze all the mutations. Our breakthrough technology provides unprecedented clarity into tumor biology to aid treatment planning. This opens up opportunities for precision diagnostics, disease surveillance and biomarker discovery.
Built by LemStudio
Yes. Isabl was funded by Y Combinator in the Winter 2020 batch. Cancer tests based on whole genome and transcriptome data.
Isabl has developed software that can analyze the entire genome of cancer patients. Today, when people get cancer, they get a genetic test of their tumor that analyzes only a few possible mutations. With Isabl, you run the tumor through an Illumina sequencer and get the whole genome, then our software is able to analy…
Isabl was part of Y Combinator's Winter 2020 batch.
Isabl has a team of 5 people according to Y Combinator's directory.
Isabl is currently listed as Active with a team of 5 in Y Combinator's directory.
Loading interactive view…